A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer

Treatment of medulloblastoma in children fails in approximately 30% of patients, and is often accompanied by severe late sequelae. Therefore, more effective drugs are needed that spare normal tissue and diminish long-term side effects. Since radiotherapy plays a pivotal role in the treatment of medu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lagerweij, Tonny, Hiddingh, Lotte, Biesmans, Dennis, Crommentuijn, Matheus H.W., Cloos, Jacqueline, Li, Xiao-Nan, Kogiso, Mari, Tannous, Bakhos A., Vandertop, W. Peter, Noske, David P., Kaspers, Gertjan J.L., Würdinger, Tom, Hulleman, Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094961/
https://www.ncbi.nlm.nih.gov/pubmed/26967057
http://dx.doi.org/10.18632/oncotarget.7980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094961/
https://www.ncbi.nlm.nih.gov/pubmed/26967057
http://dx.doi.org/10.18632/oncotarget.7980

Ejemplares similares